Lexeo Therapeutics
LXEO
LXEO
138 hedge funds and large institutions have $459M invested in Lexeo Therapeutics in 2026 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 58 increasing their positions, 37 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
5% less funds holding
Funds holding: 145 → 138 (-7)
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
40% less capital invested
Capital invested by funds: $759M → $459M (-$300M)
Holders
138
Holding in Top 10
1
Calls
$389K
Puts
$60K
Top Buyers
| 1 | +$13.1M | |
| 2 | +$10.5M | |
| 3 | +$10.1M | |
| 4 |
Goldman Sachs
New York
|
+$8.28M |
| 5 |
SSC
Spruce Street Capital
New York
|
+$5.34M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$7.16M | |
| 3 | -$6.13M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$4.43M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$4.25M |
